Context Therapeutics
CNTX
CNTX
42 hedge funds and large institutions have $43.7M invested in Context Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-10
Holders Change %
-19.23%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BOCH
Blue Owl Capital Holdings
New York
|
+$618K |
| 2 |
SC
Shay Capital
New York
|
+$85.6K |
| 3 |
Renaissance Technologies
New York
|
+$53.3K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$9.59K |
| 5 |
CWM
Congress Wealth Management
Boston,
Massachusetts
|
+$9.18K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$427K |
| 2 |
ABG
Ally Bridge Group
New York
|
-$257K |
| 3 |
AAA
Affinity Asset Advisors
New York
|
-$217K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$213K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$148K |
